Nature Communications (Apr 2023)

Vaccination of SARS-CoV-2-infected individuals expands a broad range of clonally diverse affinity-matured B cell lineages

  • Mark Chernyshev,
  • Mrunal Sakharkar,
  • Ruth I. Connor,
  • Haley L. Dugan,
  • Daniel J. Sheward,
  • C. G. Rappazzo,
  • Aron Stålmarck,
  • Mattias N. E. Forsell,
  • Peter F. Wright,
  • Martin Corcoran,
  • Ben Murrell,
  • Laura M. Walker,
  • Gunilla B. Karlsson Hedestam

DOI
https://doi.org/10.1038/s41467-023-37972-1
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 12

Abstract

Read online

Abstract Vaccination of SARS-CoV-2 convalescent individuals generates broad and potent antibody responses. Here, we isolate 459 spike-specific monoclonal antibodies (mAbs) from two individuals who were infected with the index variant of SARS-CoV-2 and later boosted with mRNA-1273. We characterize mAb genetic features by sequence assignments to the donors’ personal immunoglobulin genotypes and assess antibody neutralizing activities against index SARS-CoV-2, Beta, Delta, and Omicron variants. The mAbs used a broad range of immunoglobulin heavy chain (IGH) V genes in the response to all sub-determinants of the spike examined, with similar characteristics observed in both donors. IGH repertoire sequencing and B cell lineage tracing at longitudinal time points reveals extensive evolution of SARS-CoV-2 spike-binding antibodies from acute infection until vaccination five months later. These results demonstrate that highly polyclonal repertoires of affinity-matured memory B cells are efficiently recalled by vaccination, providing a basis for the potent antibody responses observed in convalescent persons following vaccination.